Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001864317-22-000007
Filing Date
2022-09-14
Accepted
2022-09-14 17:07:31
Documents
1
Period of Report
2022-09-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3017
  Complete submission text file 0001864317-22-000007.txt   4365
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 SHIPYARD WAY NEWPORT BEACH CA 92663
Business Address
Katzoff David J (Reporting) CIK: 0001864317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 221243642